Cargando…

Exploring a case of incompatibility in a complex regimen containing Plasma‐Lyte 148 in the pediatric intensive care

BACKGROUND: In the local pediatric intensive care unit, precipitation was observed in the intravenous catheter upon co‐administration of four drugs together with the buffered electrolyte solution (Plasma‐Lyte 148, Baxter). Co‐infusion of incompatible combinations represents a safety concern. AIMS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilsson, Niklas, Nguyen, Vivian, Nezvalova‐Henriksen, Katerina, Tho, Ingunn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098723/
https://www.ncbi.nlm.nih.gov/pubmed/36336980
http://dx.doi.org/10.1111/pan.14598
_version_ 1785024878488846336
author Nilsson, Niklas
Nguyen, Vivian
Nezvalova‐Henriksen, Katerina
Tho, Ingunn
author_facet Nilsson, Niklas
Nguyen, Vivian
Nezvalova‐Henriksen, Katerina
Tho, Ingunn
author_sort Nilsson, Niklas
collection PubMed
description BACKGROUND: In the local pediatric intensive care unit, precipitation was observed in the intravenous catheter upon co‐administration of four drugs together with the buffered electrolyte solution (Plasma‐Lyte 148, Baxter). Co‐infusion of incompatible combinations represents a safety concern. AIMS: To reproduce the clinical case of precipitation. To further explore and understand the risk of precipitation, different combinations of the components as well as the corresponding electrolyte solution with 5% glucose (Plasma‐Lyte 148 with 5% glucose) should be investigated. METHODS: Physical compatibility of fentanyl, ketamine, midazolam, and potassium chloride was tested in combination with the buffered electrolyte solutions. The concentrations and infusion rates representative of children 10–40 kg were used to estimate mixing ratios. Analyses detecting visual particles (Tyndall beam) and sub‐visual particles (light obscuration technology) were undertaken. Measured turbidity and pH in mixed samples were compared with unmixed controls. RESULTS: Both midazolam and ketamine showed formation of visual and sub‐visual particles upon mixing with Plasma‐Lyte 148, respectively. Particle formation was confirmed by increased turbidity and a distinct Tyndall effect. pH in mixed samples mirrored the pH of the buffered electrolyte, suggesting that the solubility limits of midazolam, and in some ratios also ketamine, were exceeded. Midazolam also precipitated in combination with the glucose‐containing product that held a lower pH, more favorable for keeping midazolam dissolved. CONCLUSIONS: Replication of the case revealed that both midazolam and ketamine contributed to the precipitation. Midazolam and ketamine were both evaluated as incompatible with the buffered electrolyte solution and midazolam also with the buffered electrolyte‐glucose solution and should not be co‐administered in the same i.v.‐catheter line. Fentanyl and potassium chloride were interpreted as compatible with both buffered electrolytes.
format Online
Article
Text
id pubmed-10098723
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100987232023-04-14 Exploring a case of incompatibility in a complex regimen containing Plasma‐Lyte 148 in the pediatric intensive care Nilsson, Niklas Nguyen, Vivian Nezvalova‐Henriksen, Katerina Tho, Ingunn Paediatr Anaesth Research Reports BACKGROUND: In the local pediatric intensive care unit, precipitation was observed in the intravenous catheter upon co‐administration of four drugs together with the buffered electrolyte solution (Plasma‐Lyte 148, Baxter). Co‐infusion of incompatible combinations represents a safety concern. AIMS: To reproduce the clinical case of precipitation. To further explore and understand the risk of precipitation, different combinations of the components as well as the corresponding electrolyte solution with 5% glucose (Plasma‐Lyte 148 with 5% glucose) should be investigated. METHODS: Physical compatibility of fentanyl, ketamine, midazolam, and potassium chloride was tested in combination with the buffered electrolyte solutions. The concentrations and infusion rates representative of children 10–40 kg were used to estimate mixing ratios. Analyses detecting visual particles (Tyndall beam) and sub‐visual particles (light obscuration technology) were undertaken. Measured turbidity and pH in mixed samples were compared with unmixed controls. RESULTS: Both midazolam and ketamine showed formation of visual and sub‐visual particles upon mixing with Plasma‐Lyte 148, respectively. Particle formation was confirmed by increased turbidity and a distinct Tyndall effect. pH in mixed samples mirrored the pH of the buffered electrolyte, suggesting that the solubility limits of midazolam, and in some ratios also ketamine, were exceeded. Midazolam also precipitated in combination with the glucose‐containing product that held a lower pH, more favorable for keeping midazolam dissolved. CONCLUSIONS: Replication of the case revealed that both midazolam and ketamine contributed to the precipitation. Midazolam and ketamine were both evaluated as incompatible with the buffered electrolyte solution and midazolam also with the buffered electrolyte‐glucose solution and should not be co‐administered in the same i.v.‐catheter line. Fentanyl and potassium chloride were interpreted as compatible with both buffered electrolytes. John Wiley and Sons Inc. 2022-11-21 2023-03 /pmc/articles/PMC10098723/ /pubmed/36336980 http://dx.doi.org/10.1111/pan.14598 Text en © 2022 The Authors. Pediatric Anesthesia published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Reports
Nilsson, Niklas
Nguyen, Vivian
Nezvalova‐Henriksen, Katerina
Tho, Ingunn
Exploring a case of incompatibility in a complex regimen containing Plasma‐Lyte 148 in the pediatric intensive care
title Exploring a case of incompatibility in a complex regimen containing Plasma‐Lyte 148 in the pediatric intensive care
title_full Exploring a case of incompatibility in a complex regimen containing Plasma‐Lyte 148 in the pediatric intensive care
title_fullStr Exploring a case of incompatibility in a complex regimen containing Plasma‐Lyte 148 in the pediatric intensive care
title_full_unstemmed Exploring a case of incompatibility in a complex regimen containing Plasma‐Lyte 148 in the pediatric intensive care
title_short Exploring a case of incompatibility in a complex regimen containing Plasma‐Lyte 148 in the pediatric intensive care
title_sort exploring a case of incompatibility in a complex regimen containing plasma‐lyte 148 in the pediatric intensive care
topic Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098723/
https://www.ncbi.nlm.nih.gov/pubmed/36336980
http://dx.doi.org/10.1111/pan.14598
work_keys_str_mv AT nilssonniklas exploringacaseofincompatibilityinacomplexregimencontainingplasmalyte148inthepediatricintensivecare
AT nguyenvivian exploringacaseofincompatibilityinacomplexregimencontainingplasmalyte148inthepediatricintensivecare
AT nezvalovahenriksenkaterina exploringacaseofincompatibilityinacomplexregimencontainingplasmalyte148inthepediatricintensivecare
AT thoingunn exploringacaseofincompatibilityinacomplexregimencontainingplasmalyte148inthepediatricintensivecare